Biotech Stocks Seesaw As M&A Hopes Meet New Pricing Fears
August 24, 2016 at 16:50 PM EDT
The biotech group hit a seven-month high Wednesday before reversing after Hillary Clinton attacked drug pricing again.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.